Everpure, Inc. (P) financials
NYSE · Technology · Computer Hardware · 6,400 employees · CEO Charles H. Giancarlo
- Price
- $126.98 -7.45%
- Market cap
- $42.3B
- Enterprise value
- $42.2B
- Last report
- Q2 '27 filed 2026-09-04
- Next report
- 2026-11-18 EPS est. $0.77
Valuation & key figures
- Market cap
- $42.3B EV $42.2B
- Revenue
- $4.26B Trailing 12 months
- Revenue growth
- +38% FY2027 consensus
- Profit margin
- 5.9% Net income / revenue, TTM
- P/E
- 167.1× Forward 45.6× (FY2027)
- P/S
- 9.9× Price / sales, TTM
- EV / EBITDA
- 97.9× TTM
- Free cash flow
- $128M Trailing 12 months
- Net income
- $253M Trailing 12 months
- Revenue estimate
- $5.05B FY2027 consensus
- Earnings
- 2026-11-18 Revenue est. $1.33B
- Dividend
- – No dividend
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-08-26): revenue beat by 8.0%, EPS beat by 20.7%Revenue $1.19B vs $1.1B expected (+8.0%); EPS $0.70 vs $0.58 (+20.7%).
- Revenue growth accelerating: 37.7% year on yearQ2 '27 revenue $1.19B, against an average of 21.1% over the four quarters before.
- Operating margin 5.3% (TTM), +3.0 pp on a year agoOperating income grew 195.6% while revenue grew 27.2%.
- 19.7% of pre-tax profit is non-operatingPre-tax income $279M vs operating income $224M (TTM). Gains on equity stakes and other one-off items lift net income and EPS - operating income is the cleaner measure of the business.
- Capex 7.0% of revenue (a year ago 7.5%)$300M invested in the last 4 quarters (+18.8% on a year earlier). Free cash flow $128M = 50.6% of net income.
- Returned $334M to shareholders = 260.2% of free cash flowBuybacks $334M (a year earlier $536M), dividends $0, stock-based pay $390M (TTM). More than the free cash flow: paid from cash or debt.
- Diluted share count up 2.3% in a year346M diluted shares in Q2 '27, 338M a year earlier.
- Net cash $783MCash + short-term investments $1.01B, debt incl. leases $225M; a year ago net cash $1.31B.
Last quarter: Q2 '27
Quarter ended 2026-08-02. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q2 '27 | Year ago | Change | |
|---|---|---|---|
| Revenue | $1.19B | $861M | +37.7% |
| Gross margin | 68.4% | 70.2% | -1.8 pp |
| Operating income | $63.2M | $4.87M | +1,196.6% |
| Operating margin | 5.3% | 0.6% | +4.8 pp |
| Net income | $74.1M | $47.1M | +57.4% |
| Diluted EPS | $0.21 | $0.14 | +50.0% |
| Operating cash flow | -$136M | $212M | -164.3% |
| Capex | $101M | $62M | +63.2% |
| Free cash flow | -$238M | $150M | -258.3% |
| R&D | $294M | $242M | +21.4% |
| Stock-based compensation | $0 | $117M | -100.0% |
Reported vs consensus
2026-08-26| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $1.19B | $1.1B | +8.0% |
| EPS (as estimated) | $0.70 | $0.58 | +20.7% |
From the report of 2026-08-26 for Q2 '27: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyRevenue by business line
stacked, quarterly| Segment | Q2 '27 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| Product | $687M | +53.9% | 57.9% | – | – | |
| Service | $499M | +20.4% | 42.1% | – | – |
Revenue by region
share of total| Segment | Q2 '27 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| United States | $688M | +19.3% | 58.0% | – | – | |
| Non-US | $497M | +75.2% | 42.0% | – | – |
Margins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- $428M
- Capex
- -$300M
- Buybacks
- -$334M
- Dividends
- $0
- Acquisitions
- -$130M
- Net debt issued
- -$5.1M
- Stock-based compensation
- $390M
- Free cash flow
- $128M
- Returned to shareholders / FCF
- 260.2%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 167.1× | 169.5× 4 of 5 years | 122.7× – 209.5× |
| EV / EBITDA | 97.9× | 59.4× 4 of 5 years | 45.7× – 75.5× |
| EV / Sales | 9.9× | 4.9× | 3.3× – 6.7× |
| Price / FCF | 330.1× | 29.0× | 14.5× – 41.3× |
| Price / Book | 27.4× | 12.5× | 9.4× – 16.7× |
| FCF yield | 0.3% | 3.9% | 2.4% – 6.9% |
| Return on invested capital | 6.6% | 1.2% | -4.4% – 3.4% |
| Return on equity | 17.4% | 3.0% | -19.0% – 13.0% |
Analysts
Consensus target $141.47 (+11.4%)
range $80.00 – $215.00 · rating Buy
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2027 | $5.05B | +38.0% | $2.78 | +492.1% | 45.6× | 13 |
| FY2028 | $6.91B | +36.7% | $4.19 | +50.7% | 30.3× | 13 |
| FY2029 | $8.27B | +19.7% | $5.53 | +31.9% | 23.0× | 3 |
| FY2030 | $11.9B | +44.0% | $9.52 | +72.1% | 13.3× | 1 |
| FY2031 | $7.75B | -34.9% | $4.88 | -48.7% | 26.0× | 2 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Every reported line
All 296 figures Everpure, Inc. tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).
| Line (SEC label) | Latest quarter | Year ago | y/y | Latest FY | Prior FY | y/y |
|---|---|---|---|---|---|---|
| Accounts Payable, Current | $330M | $112M | +194.1% | $153M | $112M | +36.4% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $1.03B | $530M | +93.7% | $945M | $681M | +38.8% |
| Accounts Receivable, Allowance for Credit Loss, Current | $204K | $509K | -59.9% | $203K | $940K | -78.4% |
| Accrued Marketing Costs, Current | $69.7M | $39.6M | +75.8% | $67.6M | $34.2M | +97.4% |
| Accrued Professional Fees, Current | $16.1M | $10.3M | +56.1% | $13.6M | $10.3M | +31.9% |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $670M | $594M | +12.8% | $626M | $571M | +9.6% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | -$4.55M | $1.92M | -337.6% | $1.71M | $954K | +79.1% |
| Additional Paid in Capital, Common Stock | $2.63B | $2.65B | -0.9% | $2.62B | $2.67B | -1.9% |
| Advertising Expense | – | – | – | $8.8M | $6.2M | +41.9% |
| Amortization of Intangible Assets | $1.5M | $4M | -62.5% | $13.3M | $15.7M | -15.3% |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 1.69M2026-05-03 | 23.4M | -92.8% | 514K2025-02-02 | 1.04M | -50.5% |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | $162M | $120M | +35.7% | $490M | $429M | +14.2% |
| Assets | $5.22B | $4.03B | +29.7% | $4.67B | $3.96B | +17.9% |
| Assets, Current | $3.32B | $2.52B | +31.4% | $3.06B | $2.57B | +19.3% |
| Capital Expenditures Incurred but Not yet Paid | $16.3M | $3.15M | +416.7% | $19.4M | $16.2M | +19.9% |
| Capitalized Contract Cost, Net | $447M | $340M | +31.4% | $420M | $329M | +27.7% |
| Capitalized Contract Cost, Net, Current | $150M | $105M | +43.6% | $139M | $99.3M | +40.4% |
| Capitalized Contract Cost, Net, Noncurrent | $296M | $235M | +26.0% | $280M | $229M | +22.2% |
| Cash and Cash Equivalents, at Carrying Value | $386M | $888M | -56.6% | $855M | $724M | +18.1% |
| Cash Equivalents, at Carrying Value | $258M | $279M | -7.7% | $317M | $286M | +10.6% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $396M | $910M | -56.4% | $865M | $738M | +17.2% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | -$452M | $150M | -402.4% | $127M | $25.6M | +396.6% |
| Common Stock, Capital Shares Reserved for Future Issuance | 72.2M2026-02-01 | 65.8M | +9.7% | 72.2M | 65.8M | +9.7% |
| Common Stock, Shares Authorized | 2.25B | 2.25B | 0.0% | 2.25B | 2.25B | 0.0% |
| Common Stock, Value, Issued | $33K | $33K | 0.0% | $33K | $33K | 0.0% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $71.2M | $47.2M | +50.9% | $189M | $111M | +69.5% |
| Contract with Customer, Liability, Current | $1.32B | $1.01B | +31.6% | $1.18B | $954M | +23.8% |
| Contract with Customer, Liability, Noncurrent | $1.2B | $905M | +32.3% | $1.05B | $841M | +24.4% |
| Contract with Customer, Liability, Revenue Recognized | $419M | $344M | +21.8% | $954M | $852M | +11.9% |
| Cost of Goods and Services Sold | $375M | $257M | +45.9% | $1.08B | $955M | +13.5% |
| Current Federal Tax Expense (Benefit) | – | – | – | $637K | $268K | +137.7% |
| Current Foreign Tax Expense (Benefit) | – | – | – | $24.2M | $26.6M | -9.3% |
| Current Income Tax Expense (Benefit) | – | – | – | $28.2M | $32.4M | -12.7% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $3.46M | $5.47M | -36.8% |
| Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 | $2.83M | $2.7M | +4.8% | $193K | $865K | -77.7% |
| Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five | $445M | $444M | +0.3% | $447M | $503M | -11.2% |
| Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | $177M | $199M | -11.4% | $242M | $291M | -17.0% |
| Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | $14.5M2025-11-02 | $65.2M | -77.7% | $2.03M2025-02-02 | $168M | -98.8% |
| Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | $2K2025-11-02 | $141K | -98.6% | $02025-02-02 | $2.99M | -100.0% |
| Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | $399M | $48.1M | +730.1% | $98.9M | $144M | -31.2% |
| Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | $3.19M | $31K | +10,187.1% | $105K | $208K | -49.5% |
| Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 | $2.82M | $2.73M | +3.4% | $193K | $867K | -77.7% |
| Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | $442M | $447M | -1.1% | $449M | $506M | -11.1% |
| Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | $177M | $200M | -11.4% | $243M | $292M | -16.8% |
| Debt Securities, Available-for-sale, Unrealized Loss Position | $57.5M2025-11-02 | $157M | -63.4% | $146M2025-02-02 | $463M | -68.5% |
| Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | $56K2025-11-02 | $412K | -86.4% | $208K2025-02-02 | $4.01M | -94.8% |
| DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss | $625M | $646M | -3.3% | $689M | $795M | -13.4% |
| DebtSecuritiesAvailableForSaleExcludingAccruedInterest | $622M | $650M | -4.2% | $692M | $798M | -13.3% |
| DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff | $0 | $0 | – | $0 | $0 | – |
| DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent | $622M | $650M | -4.2% | $692M | $798M | -13.3% |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | $7.86M | $8.72M | -9.9% |
| Deferred Tax Assets, Deferred Income | $113M2026-02-01 | $110M | +2.6% | $113M | $110M | +2.6% |
| Deferred Tax Assets, Gross | $1.06B2026-02-01 | $920M | +15.4% | $1.06B | $920M | +15.4% |
| Deferred Tax Assets, in Process Research and Development | $374M2026-02-01 | $430M | -13.1% | $374M | $430M | -13.1% |
| Deferred Tax Assets, Net of Valuation Allowance | $224M2026-02-01 | $164M | +36.0% | $224M | $164M | +36.0% |
| Deferred Tax Assets, Operating Loss Carryforwards | $122M2026-02-01 | $32.2M | +278.9% | $122M | $32.2M | +278.9% |
| Deferred Tax Assets, Other | $4.19M2026-02-01 | $3.24M | +29.3% | $4.19M | $3.24M | +29.3% |
| Deferred Tax Assets, Tax Credit Carryforwards | $335M2026-02-01 | $249M | +34.8% | $335M | $249M | +34.8% |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | $20.7M2026-02-01 | $19.1M | +8.6% | $20.7M | $19.1M | +8.6% |
| Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves | $40.8M2026-02-01 | $34.3M | +19.0% | $40.8M | $34.3M | +19.0% |
Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-08-02, 10-Q 2026-05-03, 10-K 2026-02-01, 10-Q 2025-11-02, 10-Q 2025-08-03, 10-Q 2025-05-04, 10-K 2025-02-02, 10-Q 2024-11-03, 10-Q 2024-08-04
Data as of 2026-11-02